Can video chats curb drinking in liver patients? new trial aims to find out
NCT ID NCT05191446
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a stepped alcohol treatment delivered via video or phone calls can help people with advanced liver disease cut back on unhealthy drinking. About 180 participants will be randomly assigned to either the treatment program or usual care. The goal is to see if the program reduces alcohol use and improves liver-related outcomes over 6 to 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
stepped alcohol treatment (motivational interviewing sessions via video or telephone)
What this could lead to
If successful, this could provide an effective way to help people with liver disease reduce harmful drinking using telehealth, potentially improving liver health and quality of life.
What could go wrong
This is a relatively small study (180 participants) and focuses on behavior change, which can be hard to sustain. Results may not apply to all patients or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of california San Francisco
San Francisco, California, 94110, United States
-
Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States